Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (1071-1080 of 7,076) with videos related to

Pageof 708
Sort By:
Drugs|June 1, 1997
Peppers and pain. The promise of capsaicinB M Fusco, M Giacovazzo
Drugs|June 1, 1997
Drug treatment of schizophrenia in the 1990s. Achievements and future possibilities in optimising outcomesW W Fleischhacker, M Hummer
Drugs|June 1, 1997
Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxificationM I Wilde, A J Wagstaff
Drugs|December 25, 2009
Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide releaseOtto Kamp, Marco Metra, Silvia Bugatti, et al.
Drugs|January 6, 2010
Does effective management of sleep disorders reduce substance dependence?Thomas Roth,
Drugs|January 6, 2010
Can improving sleep influence sleep-disordered breathing?Frédéric Sériès,
Drugs|November 22, 2005
Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritisOliver Lenz, Alessia Fornoni, Gabriel Contreras
Drugs|November 22, 2005
Continuous versus intermittent intravenous administration of antibacterials with time-dependent action: a systematic review of pharmacokinetic and pharmacodynamic parametersSofia K Kasiakou, Kenneth R Lawrence, Nicolaos Choulis, et al.
Drugs|October 27, 2009
Enzyme replacement therapy for Fabry disease: a systematic review of available evidenceRoland M Schaefer, Anna Tylki-Szymańska, Max J Hilz
Drugs|October 27, 2009
Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infectionRoberto Marcén
Pageof 708

Showing results (1071-1080 of 7,076) with videos related to

Sort By:
Pageof 708
Drugs|June 1, 1997
Peppers and pain. The promise of capsaicinB M Fusco, M Giacovazzo
Drugs|June 1, 1997
Drug treatment of schizophrenia in the 1990s. Achievements and future possibilities in optimising outcomesW W Fleischhacker, M Hummer
Drugs|June 1, 1997
Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxificationM I Wilde, A J Wagstaff
Drugs|December 25, 2009
Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide releaseOtto Kamp, Marco Metra, Silvia Bugatti, et al.
Drugs|January 6, 2010
Does effective management of sleep disorders reduce substance dependence?Thomas Roth,
Drugs|January 6, 2010
Can improving sleep influence sleep-disordered breathing?Frédéric Sériès,
Drugs|November 22, 2005
Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritisOliver Lenz, Alessia Fornoni, Gabriel Contreras
Drugs|November 22, 2005
Continuous versus intermittent intravenous administration of antibacterials with time-dependent action: a systematic review of pharmacokinetic and pharmacodynamic parametersSofia K Kasiakou, Kenneth R Lawrence, Nicolaos Choulis, et al.
Drugs|October 27, 2009
Enzyme replacement therapy for Fabry disease: a systematic review of available evidenceRoland M Schaefer, Anna Tylki-Szymańska, Max J Hilz
Drugs|October 27, 2009
Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infectionRoberto Marcén
Pageof 708